The Effect of Ultrasound-Guided Erector Spinae Plane Block on Postoperative Analgesia in Percutaneous Nephrolithotomy
1 other identifier
interventional
56
1 country
1
Brief Summary
This study is planned as a single-center randomized single blinded study and includes patients undergoing percutaneous nephrolitotomy.The aim of the study is to evaluate the effect of ultrasound guided erector spinal plane block on postoperative analgesia in percutaneous nephrolitotomy. Primary outcome is the total 24 hour morphine consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedFirst Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 29, 2026
CompletedJuly 8, 2026
June 1, 2026
1.6 years
June 23, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total 24-hour morphine consumption
Total 24-hour intravenous morphine consumption via patient controlled analgesia device
24 hours
Secondary Outcomes (10)
Pain assessment
24 hours
Additional analgesic requirement
24 hours
Postoperative nausea and vomiting
24 hours
Patient satisfaction
Up to 24 hours
Surgeon satisfaction
Up to 24 hours
- +5 more secondary outcomes
Study Arms (2)
Group erector spinae plane block (Group ESPB)
ACTIVE COMPARATORPatients received erector spinae plane block for postoperative analgesia
Group Control (Group C)
ACTIVE COMPARATORPatients received only intravenous analgesia
Interventions
Erector spinae plane block is applied in longitudinal plane at T9 level.
Inravenous morphine is administered via patient controlled analgesia device.
Eligibility Criteria
You may qualify if:
- Elective percutaneous nephrolitotomy
- American Society of Anesthesiologists (ASA) physical status I-II
You may not qualify if:
- Refusal to participate
- Coagulopathy,
- Infection at the block site
- Allergy to local anaesthetics
- Previous surgery in the block area
- Severe systemic disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University, Istanbul Faculty of Medicine
Istanbul, Fatih, 34093, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Momunat Dadashova, MD
Liv Hospital Vadi Istanbul
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Anesthesiologist
Study Record Dates
First Submitted
June 23, 2026
First Posted
June 29, 2026
Study Start
October 1, 2019
Primary Completion
April 30, 2021
Study Completion
April 30, 2021
Last Updated
July 8, 2026
Record last verified: 2026-06